FIELD: medicine pharmaceutics.SUBSTANCE: present invention refers to a pharmaceutical composition of such an active agent as sucralfate for treating disorders e.g. gastric ulcers duodenal ulcers acute gastritis symptomatic chronic gastritis gastropathy caused by the intake of anti-inflammatory agents gastroesophageal reflux disease characterised by the fact that is contains one or more phospholipids.EFFECT: invention refers to using phospholipids in a combination with the above active agents whe...

A pharmaceutical composition is described comprising sucralfate gel PVA and optionally a vegetable product comprising tocotrienols and tocopherols. In particular this composition proved to be suitable for being sprayed and is advantageously used in the treatment of skin lesions even deep lesions such as second-degree burns.

A pharmaceutical composition is described comprising sucralfate gel, PVA and optionally a vegetable product comprising tocotrienols and tocopherols. In particular, this composition proved to be suitable for being sprayed, and is advantageously used in the treatment of skin lesions, even deep lesions, such as second-degree burns.

Methods for the prevention and treatment of infection preferably antibiotic resistant wound infection using a paste formed by the reaction of sucralfate with an acid component are provided. Methods of preparing stable sucralfate compositions are disclosed. Compositions of and products containing the sucralfate paste are also described.

The invention relates to a pharmaceutical composition based on an active principle such as primarily Sucralfate for the treatment of disorders related to gastrointestinal irritation such as gastric ulcers duodenal ulcers acute gastritis symptomatic chronic gastritis gastropathy related to anti-inflammatories reflux esophagitis characterized by comprising one or more phospholipids. The invention relates to the use of phospholipids in combination with said active principle to be administered oral...

The invention relates to a pharmaceutical composition based on an active principle such as primarily Sucralfate for the treatment of disorders related to gastrointestinal irritation such as gastric ulcers duodenal ulcers acute gastritis symptomatic chronic gastritis gastropathy related to anti-inflammatories reflux esophagitis characterized by comprising one or more phospholipids. The invention relates to the use of phospholipids in combination with said active principle to be administered oral...

A sucralfate and hyaluronic acid based mucoadhesive composition of very low viscosity and its physiologically acceptable salts for the treatment and prevention of epithelial and mucosal lesions of the human body.

A sucralfate and hyaluronic acid based mucoadhesive composition of very low viscosity and its physiologically acceptable salts for the treatment and prevention of epithelial and mucosal lesions of the human body.